Vericel Corp — Director's Dealing 2010

Mar 9, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2010-03-05

Reporting Person: MAYLEBEN TIMOTHY M (Director, CEO, President, CFO & Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-05	Common Stock	P	17206	$1.452	Acquired	18068	Direct
2010-03-08	Common Stock	P	16750	$1.47	Acquired	34818	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.46, inclusive. The Reporting Person undertakes to provide Aastrom Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

F2: Reflects a 1-for-8 reverse stock split which became effective on February 18, 2010.